Phuturdex › Diseases › Otorhinolaryngologic disease
Drugs in development · updated 30 October 2026
Otorhinolaryngologic disease: drugs in development
As of 30 October 2026 there are 2 active clinical trials (recruiting or ongoing, phases I–III) on 4 drugs for otorhinolaryngologic disease. One is experimental, that is not yet approved in the United States.
Summary updated every week · data as of 30 October 2026. In Phuturdex you get the full detail of every drug and an email when an alert is published on the ones you follow.
Sign in free →Experimental drugs
Not yet approved by the US FDA for any indication.
| Drug | Most advanced phase | Active trials | Reference trial |
|---|---|---|---|
| AC102 gel | II | 1 | NCT05776459 |
Sorted by most advanced phase and number of active trials.
Approved drugs in new trials
Approved by the US FDA for at least one indication, not necessarily this disease, and now in active trials on it.
| Drug | Most advanced phase | Active trials | Reference trial |
|---|---|---|---|
| CarboplatinCarboplatine, Paraplatin | II | 1 | NCT05388773 |
| CisplatinCis Platinum, Cisplatine | II | 1 | NCT05388773 |
| PrednisolonePrednisolon, Prenisolone | II | 1 | NCT05776459 |
Sorted by most advanced phase and number of active trials.
All 4 drugs, with the details
In Phuturdex every drug has all its trials, sponsors and countries, FDA and EMA approvals, orphan designations and safety alerts. Free until 31 March 2027.
Open in Phuturdex →Specific forms
- Nasopharyngeal Carcinoma 71 drugs
- Oropharyngeal Neoplasms 46 drugs
- Head and neck squamous cell carcinoma 321 drugs
- Laryngeal neoplasm 35 drugs
- Mouth Neoplasms 49 drugs
- Head and neck neoplasms 184 drugs
- Hypopharyngeal Neoplasms 33 drugs
- Nasopharyngeal neoplasm 32 drugs
- Carcinoma 137 drugs
- Non-small-cell lung carcinoma 726 drugs
- Metastasis 493 drugs
- Squamous cell carcinoma 72 drugs
Broader categories
- Urogenital Diseases 16 drugs
- Neoplasm 671 drugs
- Nervous System Diseases 39 drugs
- Genital Diseases 7 drugs
- Carcinoma 137 drugs
- Infection 71 drugs
Source: Phuturdex analysis of ClinicalTrials.gov data (U.S. National Library of Medicine), updated 30 October 2026. Active trials = recruiting or ongoing, phases I–III, with at least one identified drug; phase and sites refer to the trials on this disease. Disease name: Wikidata; NLM MeSH term: D010038 “Otorhinolaryngologic Diseases”.